|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
3
|
Dela Cruz CS, Tanoue LT and Matthay RA:
Lung cancer: Epidemiology, etiology, and prevention. Clin Chest
Med. 32:605–644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Steliga MA and Dresler CM: Epidemiology of
lung cancer: Smoking, secondhand smoke, and genetics. Surg Oncol
Clin N Am. 20:605–618. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yano T, Haro A, Shikada Y, Maruyama R and
Maehara Y: Non-small cell lung cancer in never smokers as a
representative 'non-smoking-associated lung cancer': Epidemiology
and clinical features. Int J Clin Oncol. 16:287–293. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Villar Álvarez F, Muguruza Trueba I and
Vicente Antunes SI: Notes on recurrence and second tumors in lung
cancer. Arch Bronconeumol. 52:545–546. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng J, Wang F, Lu S and Wang X: LASP-1,
regulated by miR-203, promotes tumor proliferation and
aggressiveness in human non-small cell lung cancer. Exp Mol Pathol.
100:116–124. 2016. View Article : Google Scholar
|
|
8
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Temel JS, Greer JA, Muzikansky A,
Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD,
Jacobsen J, Pirl WF, et al: Early palliative care for patients with
metastatic non-small-cell lung cancer. N Engl J Med. 363:733–742.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tomasetto C, Moog-Lutz C, Régnier CH,
Schreiber V, Basset P and Rio MC: Lasp-1 (MLN 50) defines a new LIM
protein subfamily characterized by the association of LIM and SH3
domains. FEBS Lett. 373:245–249. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Orth MF, Cazes A, Butt E and Grunewald TG:
An update on the LIM and SH3 domain protein 1 (LASP1): A versatile
structural, signaling, and biomarker protein. Oncotarget. 6:26–42.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Segerer SE, Bartmann C, Kaspar S, Müller
N, Kapp M, Butt E and Kämmerer U: The cytoskeletal protein LASP-1
differentially regulates migratory activities of choriocarcinoma
cells. Arch Gynecol Obstet. 293:407–414. 2016. View Article : Google Scholar
|
|
13
|
Rachlin AS and Otey CA: Identification of
palladin isoforms and characterization of an isoform-specific
interaction between Lasp-1 and palladin. J Cell Sci. 119:995–1004.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Grunewald TG and Butt E: The LIM and SH3
domain protein family: Structural proteins or signal transducers or
both? Mol Cancer. 7:312008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Duvall-Noelle N, Karwandyar A, Richmond A
and Raman D: LASP-1: A nuclear hub for the UHRF1-DNMT1-G9a-Snail1
complex. Oncogene. 35:1122–1133. 2016. View Article : Google Scholar
|
|
16
|
Frietsch JJ, Grunewald TG, Jasper S,
Kammerer U, Herterich S, Kapp M, Honig A and Butt E: Nuclear
localisation of LASP-1 correlates with poor long-term survival in
female breast cancer. Br J Cancer. 102:1645–1653. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Grunewald TG, Kammerer U, Schulze E,
Schindler D, Honig A, Zimmer M and Butt E: Silencing of LASP-1
influences zyxin localization, inhibits proliferation and reduces
migration in breast cancer cells. Exp Cell Res. 312:974–982. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Grunewald TG, Kammerer U, Winkler C,
Schindler D, Sickmann A, Honig A and Butt E: Overexpression of
LASP-1 mediates migration and proliferation of human ovarian cancer
cells and influences zyxin localisation. Br J Cancer. 96:296–305.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng J, Yu S, Qiao Y, Zhang H, Liang S,
Wang H, Liu Y, Zhou F, Jiang J and Lu S: LASP-1 promotes tumor
proliferation and metastasis and is an independent unfavorable
prognostic factor in gastric cancer. J Cancer Res Clin Oncol.
140:1891–1899. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang H, Li Z, Chu B, Zhang F, Zhang Y, Ke
F, Chen Y, Xu Y, Liu S, Zhao S, et al: Upregulated LASP-1
correlates with a malignant phenotype and its potential therapeutic
role in human cholangiocarcinoma. Tumour Biol. 37:8305–8315. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao L, Wang H, Liu C, Liu Y, Wang X, Wang
S, Sun X, Li J, Deng Y, Jiang Y, et al: Promotion of colorectal
cancer growth and metastasis by the LIM and SH3 domain protein 1.
Gut. 59:1226–1235. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin X, Liu X, Fang Y and Weng X: LIM and
SH3 protein 1 promotes tumor proliferation and metastasis in lung
carcinoma. Oncol Lett. 12:4756–4760. 2016.
|
|
23
|
Yang F, Zhou X, Du S, Zhao Y, Ren W, Deng
Q, Wang F and Yuan J: LIM and SH3 domain protein 1 (LASP-1)
overexpression was associated with aggressive phenotype and poor
prognosis in clear cell renal cell cancer. PLoS One. 9:e1005572014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Akiyama H, Chaboissier MC, Martin JF,
Schedl A and de Crombrugghe B: The transcription factor Sox9 has
essential roles in successive steps of the chondrocyte
differentiation pathway and is required for expression of Sox5 and
Sox6. Genes Dev. 16:2813–2828. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Spokony RF, Aoki Y, Saint-Germain N,
Magner-Fink E and Saint-Jeannet JP: The transcription factor Sox9
is required for cranial neural crest development in Xenopus.
Development. 129:421–432. 2002.PubMed/NCBI
|
|
26
|
Chaboissier MC, Kobayashi A, Vidal VI,
Lützkendorf S, van de Kant HJ, Wegner M, de Rooij DG, Behringer RR
and Schedl A: Functional analysis of Sox8 and Sox9 during sex
determination in the mouse. Development. 131:1891–1901. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Müller P, Crofts JD, Newman BS,
Bridgewater LC, Lin CY, Gustafsson JA and Ström A: SOX9 mediates
the retinoic acid-induced HES-1 gene expression in human breast
cancer cells. Breast Cancer Res Treat. 120:317–326. 2010.
View Article : Google Scholar
|
|
28
|
Qin GQ, He HC, Han ZD, Liang YX, Yang SB,
Huang YQ, Zhou L, Fu H, Li JX, Jiang FN, et al: Combined
overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical
recurrence-free survival in patients with prostate cancer. Onco
Targets Ther. 7:137–146. 2014.PubMed/NCBI
|
|
29
|
Bruun J, Kolberg M, Nesland JM, Svindland
A, Nesbakken A and Lothe RA: Prognostic significance of β-catenin,
E-cadherin, and SOX9 in colorectal cancer: Results from a large
population-representative series. Front Oncol. 4:1182014.
View Article : Google Scholar
|
|
30
|
Jiang SS, Fang WT, Hou YH, Huang SF, Yen
BL, Chang JL, Li SM, Liu HP, Liu YL, Huang CT, et al: Upregulation
of SOX9 in lung adenocarcinoma and its involvement in the
regulation of cell growth and tumorigenicity. Clin Cancer Res.
16:4363–4373. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang X, Ju Y, Zhou MI, Liu X and Zhou C:
Upregulation of SOX9 promotes cell proliferation, migration and
invasion in lung adenocarcinoma. Oncol Lett. 10:990–994.
2015.PubMed/NCBI
|
|
32
|
Wang X, Liu Y, Liu X, Yang J, Teng G,
Zhang L and Zhou C: MiR-124 inhibits cell proliferation, migration
and invasion by directly targeting SOX9 in lung adenocarcinoma.
Oncol Rep. 35:3115–3121. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou CH, Ye LP, Ye SX, Li Y, Zhang XY, Xu
XY and Gong LY: Clinical significance of SOX9 in human non-small
cell lung cancer progression and overall patient survival. J Exp
Clin Cancer Res. 31:182012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Grunewald TG, Kammerer U, Kapp M, Eck M,
Dietl J, Butt E and Honig A: Nuclear localization and cytosolic
overexpression of LASP-1 correlates with tumor size and
nodal-positivity of human breast carcinoma. BMC Cancer. 7:1982007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang H, Shi J, Luo Y, Liao Q, Niu Y, Zhang
F, Shao Z, Ding Y and Zhao L: LIM and SH3 protein 1 induces
TGFβ-mediated epithelial-mesenchymal transition in human colorectal
cancer by regulating S100A4 expression. Clin Cancer Res.
20:5835–5847. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hailer A, Grunewald TG, Orth M, Reiss C,
Kneitz B, Spahn M and Butt E: Loss of tumor suppressor mir-203
mediates overexpression of LIM and SH3 protein 1 (LASP1) in
high-risk prostate cancer thereby increasing cell proliferation and
migration. Oncotarget. 5:4144–4153. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shimizu F, Shiiba M, Ogawara K, Kimura R,
Minakawa Y, Baba T, Yokota S, Nakashima D, Higo M, Kasamatsu A, et
al: Overexpression of LIM and SH3 protein 1 leading to accelerated
G2/M phase transition contributes to enhanced tumourigenesis in
oral cancer. PLoS One. 8:e831872013. View Article : Google Scholar
|
|
38
|
Dejima T, Imada K, Takeuchi A, Shiota M,
Leong J, Tombe T, Tam K, Fazli L, Naito S, Gleave ME, et al:
Suppression of LIM and SH3 domain protein 1 (LASP1) negatively
regulated by androgen receptor delays castration resistant prostate
cancer progression. Prostate. 77:309–320. 2017. View Article : Google Scholar
|
|
39
|
Raman D, Sai J, Neel NF, Chew CS and
Richmond A: LIM and SH3 protein-1 modulates CXCR2-mediated cell
migration. PLoS One. 5:e100502010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Felipe Lima J, Nofech-Mozes S, Bayani J
and Bartlett JM: EMT in breast carcinoma-A review. J Clin Med.
5:E652016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang B, Feng P, Xiao Z and Ren EC: LIM and
SH3 protein 1 (Lasp1) is a novel p53 transcriptional target
involved in hepatocellular carcinoma. J Hepatol. 50:528–537. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhao T, Ren H, Li J, Chen J, Zhang H, Xin
W, Sun Y, Sun L, Yang Y, Sun J, et al: LASP1 is a HIF1α target gene
critical for metastasis of pancreatic cancer. Cancer Res.
75:111–119. 2015. View Article : Google Scholar
|
|
43
|
Loughran G, Huigsloot M, Kiely PA, Smith
LM, Floyd S, Ayllon V and O'Connor R: Gene expression profiles in
cells transformed by overexpression of the IGF-I receptor.
Oncogene. 24:6185–6193. 2005. View Article : Google Scholar : PubMed/NCBI
|
